RxDoctor Payments Data

Prathima Anandi, MD

Pain Medicine · Shreveport, LANPI 1750842290

Payments from drug & device makers

What this record shows

This record is dominated by grants: $13,333 of the $19,253 with a category attached, or 69.3%. 17 manufacturers reported payments, led by Medtronic at 54.6% of the total. Reporting peaked in 2023 at $12,061 and has fallen 92.7% since, to $884 in 2025. Among pain medicine clinicians in LA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$19,253in general payments, 2019–2025

Across 79 payments — averaging $243.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$11K
  • Boston Scientific$7K
  • Curonix LLC$306
  • Nevro Corp.$293
  • Saluda Medical Americas, Inc.$287
  • Abbott$165
  • plus $697 from 11 others

What the payments were for

  • Grants$13,33369%
  • Travel & lodging$3,19617%
  • Food & beverage$2,72414%

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$19,253 in reported general payments places this provider in the 90th percentile of 97 pain medicine providers in Louisiana.

See all pain medicine providers in Louisiana

Medicare billing

Part B allowed, 2024
$33,641
Medicare patients
133
Services billed
475

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin62$998
Duloxetine Hcl21$673
Pregabalin46$618
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen14$467
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen18$450
Methocarbamol33$361
Baclofen22$219
Meloxicam37$128

Paid to pharmacies, not to this prescriber.

Other pain medicine in Shreveport

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →